Controlled trial of clofibrate in cerebral vascular disease

      This paper is only available as a PDF. To read, Please Download here.


      A controlled trial of Clofibrate in 95 patients with established cerebral vascular disease is described. The level of serum cholesterol is significantly lowered in patients on treatment compared with control patients. There is no evidence to indicate that lowering the level of serum cholesterol in patients with established cerebral vascular disease has affected either the incidence of further episodes of cerebral ischaemia or the mortality rate.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Meyer J.S.
        • Waltz A.G.
        • Hess J.W.
        • Zak B.
        Serum lipids and cholesterol levels in cerebrovascular disease.
        Arch. Neurol. (Chic.). 1959; 1: 303
        • Heyman A.
        • Nefzger M.D.
        • Estes E.H.
        Serum cholesterol level in cerebral infarction.
        Arch. Neurol. (Chic.). 1961; 5: 264
        • Thorp J.M.
        Experimental evaluation of an orally active combination of androsterone with ethyl chlorophenoxyisobutyrate.
        Lancet. 1962; 1: 1323
        • Oliver M.F.
        Reduction of serum-lipid and uric-acid levels by an orally active androsterone.
        Lancet. 1962; 1: 1321
        • Acheson J.
        • Hutchinson E.C.
        A controlled trial of Atromid in cerebral vascular disease. A preliminary report.
        J. Atheroscler. Res. 1963; 3: 711
        • Acheson J.
        • Hutchinson E.C.
        The natural history of ‘focal cerebrovascular disease’.
        Quart. J. Med. 1971; 40 (New series): 15
        • Kaanel W.B.
        • Dawber T.R.
        • Cohen M.E.
        • McNamara P.M.
        Vascular disease of the brain-epidemiological aspects: The Framingham study.
        Amer. J. Publ. Hlth. 1965; 55: 1355
        • Dayton S.
        • Pearce M.L.
        • Hashimoto S.
        • Dixon W.J.
        • Tomiyasu U.
        A controlled clinical trial of a diet high in unsaturated fat.
        Circulation. 1969; 40: 1
        • Acheson J.
        Factors affecting the natural history of “focal cerebrovascular disease”.
        Quart. J. Med. 1971; 40 (New series): 25
        • Oliver M.F.
        • Stuart-Harris C.H.
        Present position concerning prevention of heart disease.
        Brit. Med. J. 1965; 2: 1203